Page 2 - Ramesh Swaminathan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ramesh swaminathan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ramesh Swaminathan Today - Breaking & Trending Today

Why the PLI scheme, despite a tepid start, could see things change for the better

Designed to boost India’s manufacturing capabilities and exports, the production-linked incentive scheme has had a tepid beginning. Things might begin to change in FY24, with economic activity predicted to normalise ....

Rajya Sabha , Guruprasad Mohapatra , Ramesh Swaminathan , Rameswar Teli , Chanakya Chaudhary , Hetal Gandhi , Arnav Das Sharma , Arnab Dutta , Raghuram Rajan , Parameswaran Iyer , Vijay Sharma , Pankaj Mohindroo , Rajeev Chandrasekhar , Kanwaljeet Jawa , Vipul Prasad , Thornton Bharat , Amitabh Kant , Union Budget , Conditioner Manufacturers Association , Department For Promotion Of Industry , Corporate Services At Tata Steel , National Steel , Johnson Controls , Ministry Of Heavy Industries , Electronics Association , Head Of Corporate Affairs ,

Lupin receives US regulator's approval for Cyanocobalamin nasal spray

The nasal spray manufactured by Lupin is a generic version of Nascobal nasal spray ....

United States , Ramesh Swaminathan , Vinita Gupta , Drug Administration , United States Food ,

Lupin hits 52-week high on buzz of API business demerger

Lupin s rival Glenmark Pharma had undergone a similar restructuring when it hived off its API business into a new company, Glenmark Life Sciences. ....

Glenmark Pharma , Ramesh Swaminathan , Vinita Gupta , National Stock Exchange , Glenmark Life Sciences , Glenmark Life , Uzzing Stocks , Pharma Company ,

Can the Gupta siblings solve Lupin's US puzzle?

The US has been a sore point in the pharma company’s business. A turnaround is in the works.Lupin’s US revenue has shrunk while its margins are the worst among pharma companies. A series of setbacks regulatory troubles, price erosion and impairments have impacted the company. ....

Madhya Pradesh , Southern Cross , Desh Bandu , Manju Gupta , Ramesh Swaminathan , Desh Bandhu , Novel Laboratories Inc , Bausch Medical Companies Inc , Southern Cross Pharmaceuticals , Drug Administration , Gavis Pharmaceuticals , Symbiomix Therapeutics , World Health Organization , Boehringer Ingelheim , Novel Laboratories , Desh Bandu Gupta , Lupin Ltd , Us Market ,

Lupin likely to demerge its active pharmaceutical ingredients business

As such the API business contributes around 7 percent to Lupin's overall turnover ....

Ramesh Swaminathan , Glenmark Lifesciences , Vinita Gupta , Nilesh Gupta , Business Standard , Axis Securities , Pharma Company , Active Pharmaceutical Ingredients , Upin Api Busness ,